Chemotherapy Administration
Historically, the fellowship training at Mount Sinai was recognized for the ability of fellows to provide comprehensive management of all patients including control of chemotherapy administration to all gynecologic oncology patients at the institution. In the last ten years, however, the ability to administer chemotherapy has been challenged by restrictions in reimbursement and institutional support. The outpatient gynecologic oncology infusion fiscally managed by the hospital and incurred a major fiscal deficit. The service was in jeopardy of being discontinued because it was considered to be unprofitable, however the Division took the bold step of assuming total fiscal and administrative control of the chemo-infusion service and has now brought the fiscal operation into the black. In addition, during the last 18 months, the infusion service was successfully relocated to a new home in the Ruttenberg Treatment Center. Under this new paradigm, all of the gyn-oncology chemotherapy infusion is administered with a gyn oncology attending physically present. Over 750 cycles of chemotherapy are administered by the Division annually, and all of the chemotherapy orders are written by the fellows under direct tutelage and supervision of the Faculty.
Daily Chemotherapy Review
On a daily basis, all of the Chemotherapy administration orders are written by the Fellow on service and reviewed with the Director of the Gyn Oncology Chemo-Infusion Service (Dr Rahaman) or another designated Attending. This review allows the fellow the opportunity to discuss the nuances of clinical pharmacology, and review the literature and data justifying the regimens being utilized.
Medical Oncology Rotation
During this rotation, the fellow not only learns principles of “cancer medicine” but is exposed to a variety of investigators in different cancer disciplines. The fellow acquires the expertise to manage patients who have acquired the adverse effects of chemotherapeutic and immunotherapeutic programs, learns protocol design, interacts with the statistical and data retrieval branch of the institution’s cancer center core activity, and learns about the clinical research efforts of a variety of national collaborators. The fellow also attends didactics on clinical pharmacology and non-gynecologic chemotherapy regimens.
Gynecologic Pathology
The fellow rotates through the Department of Pathology working directly in the Division of Gynecologic Pathology with Dr. Liane Deligdisch, Dr. Tamara Kalir, and Dr. Peter Schlosshauer, all of whom are board certified pathologists with special training in gynecologic pathology. While the fellow is on that service there is no other gynecologic trainee. In the mornings, the major pathology “sign-outs” are performed with the fellow reviewing each specimen on the multi-headed microscope. In the afternoon all of the minor cases are similarly diagnosed. The purpose is to ensure expertise in interpreting histologic sections and in acquiring familiarity with research techniques being employed in gynecologic pathology. This initial exposure often results in joint study between the fellow and Dr. Deligdisch for the remainder of the fellowship. This interaction continues on an informal basis because of time constraints; however, the fellow meets with Dr. Deligdisch prior to the Monday afternoon gynecologic oncology conference so as to review all of the specimens collected during the previous week in order to present the conference.
Radiation Therapy
The fellow spends two months in the Department of Radiation Therapy, working under the direction of Dr. Richard Stock, the department director, and his staff, especially Dr. Sheryl Green who is devoted to the radiation therapy for gynecologic oncology. This department is committed to the education of our fellow and since there are few extramural rotators through the department, the staff, including the physicists and radiotherapy technologists, has an opportunity to provide “hands on” preceptorship. This allows participation in the management of all patients with gynecologic cancers. Our fellows’ education can occur by virtue of a supervised “hands on” preceptorial program which will allow participation in the management of all patients with gynecologic cancers, as well as, all patients being planned, localized, and started on radiotherapeutic programs. There are didactics in radiation physics, as well as daily instruction in radiation physics designed to meet the needs of a gynecologic oncologist as outlined by the Division. All patients with gynecologic cancers requiring admission to hospital are admitted on the gynecologic oncology service and their in-hospital care is supervised by the fellow in gynecologic oncology under the direction of the radiation therapist. This applies not only during the fellows’ rotation through radiation therapy but also carries over to all radiation therapy admissions of gynecologic oncology patients. All low-dose brachytherapy procedures are performed by the gynecologic oncology fellow under attending supervision. Because there is a larger cohort of advanced cervical cancer patients requiring brachytherapy at our Queen’s affiliate, the fellows attend the high-dose rate brachytherapy applications for cervical cancer at the Queen’s Hospital Center, during the Radiation Oncology rotation. These sessions are conducted under the supervision of the Radiation Oncology Faculty.